Crossmark

Cardiac adverse events associated with statins in myocardial infarction patients: a pharmacovigilance analysis of the FDA Adverse Event Reporting System

Crossref DOI link: https://doi.org/10.1007/s11096-024-01804-z

Published Online: 2024-11-06

Published Print: 2025-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Deng, Chuanhuan

Lin, Xiaofang

Ni, Dan

Yuan, Ludong

Li, Jing

Liu, Yuxuan

Liang, Pengfei

Jiang, Bimei https://orcid.org/0000-0001-5231-048X
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (No. 81971820)
License Information

Text and Data Mining valid from 2024-11-06

Version of Record valid from 2024-11-06
More Information

Article History

Received: 4 July 2024

Accepted: 6 September 2024

First Online: 6 November 2024

Conflicts of interest

: The authors declare no conflict of interest.

Document is current

Any future updates will be listed below